Microphysiological systems to advance human pathophysiology and translational medicine
- 1 November 2024
- journal article
- review article
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 137 (5) , 1494-1501
Abstract
Microphysiological systems (MPS) or “organ-on-a-chip” models are sophisticated tools that harness techniques from cell biology, tissue engineering, and microengineering to recapitulate human physiology. Typically, MPS are biofabricated three-dimensional (3-D) tissue constructs integrated into platforms designed to mimic the tissue microenvironment and provide functional outputs. Over the past decade, researchers have endeavored to manufacture high-throughput, high-fidelity MPS models of all major human organs. By incorporating patient-derived cells, researchers have produced biomimetic models of tissues with disease-linked genetic mutations capable of exhibiting patient heterogeneity. This work has demonstrated that MPS more closely model organotypic function and pathophysiology than traditional two-dimensional (2-D) culture systems. Moreover, investigators have shown that human MPS are better predictors of drug efficacy and toxicity than animal models. Thus, MPS have emerged as a promising candidate to improve the efficacy and safety of preclinical trials. In this mini-review, we provide an overview of current advances in MPS models, their applications in mechanistic research, and relevance to drug screening. Finally, we discuss current investments in MPS development by the United States federal government and research institutions around the world to advance translational medicine.Keywords
Funding Information
- Center for the Advancement of Science in Space (GA-2023-9024)
- HHS | NIH | National Center for Advancing Translational Sciences (UH3TR003519)
- HHS | NIH | National Center for Advancing Translational Sciences (UH3TR003271)
- HHS | NIH | National Heart, Lung, and Blood Institute (R01HL164936)
- HHS | NIH | National Heart, Lung, and Blood Institute (R01HL156947)
- HHS | NIH | National Heart, Lung, and Blood Institute (R01HL146436)
- HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (5R01AR071614, P30 AG028747)
- HHS | NIH | National Institute of General Medical Sciences (K12-GM123914)
- HHS | NIH | National Institute of Neurological Disorders and Stroke (R01NS094388)
- National Science Foundation (Grant 2323013)
This publication has 68 references indexed in Scilit:
- Microphysiological Blood‐Brain Barrier Systems for Disease Modeling and Drug DevelopmentAdvanced Healthcare Materials, 2024
- Biomanufacturing of 3D Tissue Constructs in Microgravity and their Applications in Human Pathophysiological StudiesAdvanced Healthcare Materials, 2023
- Bone‐on‐a‐Chip: Microfluidic Technologies and Microphysiologic Models of Bone TissueAdvanced Functional Materials, 2020
- Is it Time for Reviewer 3 to Request Human Organ Chip Experiments Instead of Animal Validation Studies?Advanced Science, 2020
- Liver‐on‐a‐Chip Models of Fatty Liver DiseaseHepatology, 2020
- Construction of pancreas–muscle–liver microphysiological system (MPS) for reproducing glucose metabolismBiotechnology and Bioengineering, 2019
- Liver Microphysiological Systems for Predicting and Evaluating Drug EffectsClinical Pharmacology & Therapeutics, 2019
- Advances in Microfluidics‐Based Assisted Reproductive Technology: From Sperm Sorter to Reproductive System‐on‐a‐ChipAdvanced Biosystems, 2018
- Long‐term maintenance of a microfluidic 3D human liver sinusoidBiotechnology and Bioengineering, 2015
- An artificial liver sinusoid with a microfluidic endothelial‐like barrier for primary hepatocyte cultureBiotechnology and Bioengineering, 2007